STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
STAAR Surgical (STAA) Tops Q3 EPS by 10c, Revenues Beat; 'Raises Outlook for Full Year 2018'
October 31, 2018 4:05 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q3 EPS of $0.07, $0.10 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $31.8 million versus the consensus estimate of $29.02 million.
Net Sales of $31.8 Million Up 35% from the Prior Year QuarterICL Sales Up 46% and Units Up 56% from the Prior Year QuarterGross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year QuarterEarnings per Share of $0.03 versus Earnings per Share of $0.03 in the Prior Year QuarterNon-GAAP Earnings per Share of $0.07 versus Earnings per Share of $0.04 in the Prior Year... More